Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine
Authors:
- Richard Mw HoetelmansRHRichard Mw Hoetelmans
- Joep Ma LangeJLJoep Ma Lange
- Frank de WolfFWFrank de Wolf
- Birgit Hb van BenthemBBBirgit Hb van Benthem
- Jaap J MaasJMJaap J Maas
- Ireneus Pm KeetIKIreneus Pm Keet
- Peter PortegiesPPPeter Portegies
- 1 May 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 351 (9115) , 1547-1551
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A Novel Approach to Assessing the Drug Susceptibility and Replication of Human Immunodeficiency Virus Type 1 IsolatesThe Journal of Infectious Diseases, 1997
- Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR resultsThe Lancet, 1997
- The Effect on Human Immunodeficiency Virus Type 1 RNA Levels in Cerebrospinal Fluid after Initiation of Zidovudine or DidanosineThe Journal of Infectious Diseases, 1997
- Pilot study of the efficacy of atevirdine in the treatment of AIDS dementia complexAIDS, 1996
- StavudineDrugs, 1996
- Diagnosis of Herpes Simplex Encephalitis: Application of Polymerase Chain Reaction to Cerebrospinal Fluid from Brain-Biopsied Patients and Correlation with DiseaseThe Journal of Infectious Diseases, 1995
- Cerebrospinal fluid human immunodeficiency virus type 1 (HIV‐1) p24 antigen levels in HIV‐1–related dementiaAnnals of Neurology, 1994
- Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIVAIDS, 1993
- Pharmacokinetics of Stavudine in Patients with AIDS or AIDS-Related ComplexThe Journal of Infectious Diseases, 1992
- Effect of Zidovudine on Cerebrospinal Fluid in Patients with HIV Infection and Acute Neurological DiseaseScandinavian Journal of Infectious Diseases, 1991